Comment on "The abrupt cessation of therapeutically administered sodium oxybate (GHB) may cause withdrawal symptoms".
Zvosec
Deborah L
DL
Smith
Stephen W
SW
D002385:Cataplexy / Q000150:complications / Q000503:physiopathology; D006801:Humans; D012189:Retrospective Studies; D012978:Sodium Oxybate / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000503:physiopathology
D012978:Sodium Oxybate